Xvivo: No weakness after the robust first quarter - Redeye

The Thoracic recovery continues, and the organic growth in constant currencies is a robust 24% compared with 32% in the earlier Q1. The Abdominal organic growth is a very reassuring 51%, and organic growth for Services is 40%. Disposable growth and gross margins are leading value drivers for XVIVO, and the gross margins improved in both Thoracic (+300bp) and Abdominal disposables (+600bp). The Q2 organic growth in disposables is at 16-17% in the teens.

Länk till analysen i sin helhet: https://www.redeye.se/research/848480/xvivo-q2-2022-no-weakness-after-the-robust-first-quarter?utm_source=finwire&utm_medium=RSS